MarketInOut Stock Screener Log In | Sign Up

Procter & Gamble Health Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:31
Procter & Gamble Health Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization83,246 mln
Float7.94 mln
Earnings Date11/02/2026

EPS

215
Exceptional

P / E

25.09
Elevated

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-0.61
Highly suspicious

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.02
Debt-free

Business Description

Procter & Gamble Health Limited is an India-based company that sells health and wellness products to consumers both domestically and abroad. Its range includes vitamins, minerals, supplements, and other non-prescription health products sold under well-known names such as Neurobion, Evion, Livogen, and Seven Seas. Founded in 1967 and based in Mumbai, the company operates as part of the broader Procter & Gamble group.

Key Fundamentals

EPS215
P/E25.09
ROE58.33
RPS768
ROIC72.13
ROA38.76
Interest Cover787
EBITDA, mln4,740
EV / EBITDA19.65
EV / EBIT20.68
Revenue, mln14,080
EV / Revenue6.61

Quote Details

Last 5,399.00
Change -90 (-1.64%)
Open 5,475.00
Volume 6,327
Turnover 34,159,472
Average Volume 14,144

Financial Ratios

Pre-Tax Profit Margin32
Current Ratio2.18
Price / Book17.67
Price / Tangible Book17.68
Price / Cash Flow48.19
Price / Free Cash Flow193
Debt / Equity0.02
Price / Sales6.58
PEG Ratio1.93

Financial Strength

Altman Z-Score22.09
Piotroski F-Score 5 / 9
Beneish M-Score-0.61
Price to Intrinsic Value9.29
Price to Lynch Fair Value2.82
Price to Graham Number4.72
Shiller PE Ratio29.50

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.95% 94 / 100   
1 Month -0.13% 83 / 100   
2 Months -19.74% 20 / 100   
6 Months 5.14% 70 / 100   
1 Year -10.23% 56 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog